Association of adiponectin and metabolic syndrome in women

Journal of Research in Medical Sciences

Volumn 16, Issue 12, 2011, Pages 1532-1540

  Sanjari, Mojgan ^a   Khodashahi, Mandana ^b   Gholamhoseinian, Ahmad ^b   Shokoohi, Mostafa ^c  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adiponectin; Blood pressure; Body mass index; Metabolic syndrome; Women

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IRAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; SOCIAL STATUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WOMEN'S HEALTH;

EID: 84855777588     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascu- lar diseases in Korea. J Korean Med Sci 2004; 19(2): 195-201.
2. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge M, St-Pierre DH, Tremblay-Lebeau A, et al. Metabolic and beha- vioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89(10): 5013-20.
3. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365(9468): 1415-28.
4. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality asso- ciated with the metabolic syndrome. Diabetes Care 2001; 24(4): 683-9.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002; 288(21): 2709-16.
6. Mohammadzadeh G, Zarghami N. Hypoadiponectinemia in obese subjects with type II diabetes: A close association with central obesity indices. J Res Med Sci 2011; 16(6): 713-23.
7. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287(3): 356-9.
8. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004; 27(10): 2444-9.
9. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, et al. Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol 2003; 18(4): 311-9.
10. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance be- tween the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract 2007; 77(2): 251-7.
11. Delavar MA, Lye MS, Khor GL, Hanachi P, Hassan ST. Prevalence of metabolic syndrome among middle aged women in Babol, Iran. Southeast Asian J Trop Med Public Health 2009; 40(3): 612-28.
12. Gharipour M, kelishadi R, Baghaie M, Boshtam M, Rabeie K. Prevalence of metabolic syndrome in an Iranian adult population. ARYA Journal 2006; 1(3): 188-92.
13. Vasseur F. Adiponectin and its receptors: partners contributing to the vicious circle leading to the metabolic syn- drome? Pharmacol Res 2006; 53(6): 478-81.
14. Chandran M, Phillips SA, Ciaraldi T, Henry RR. Adiponectin: more than just another fat cell hormone? Diabetes Care 2003; 26(8): 2442-50.
15. Mojiminiyi OA, Abdella NA, Al AM, Ben NA. Adiponectin, insulin resistance and clinical expression of the meta- bolic syndrome in patients with Type 2 diabetes. Int J Obes (Lond) 2007; 31(2): 213-20.
16. Yoon SJ, Lee HS, Lee SW, Yun JE, Kim SY, Cho ER, et al. The association between adiponectin and diabetes in the Korean population. Metabolism 2008; 57(6): 853-7.
17. Jalovaara K, Santaniemi M, Timonen M, Jokelainen J, Kesaniemi YA, Ukkola O, et al. Low serum adiponectin level as a predictor of impaired glucose regulation and type 2 diabetes mellitus in a middle-aged Finnish population. Metabolism 2008; 57(8): 1130-4.
18. Sheng T, Yang K. Adiponectin and its association with insulin resistance and type 2 diabetes. J Genet Genomics 2008; 35(6): 321-6.
19. Frystyk J, Berne C, Berglund L, Jensevik K, Flyvbjerg A, Zethelius B. Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men. J Clin Endocrinol Metab 2007; 92(2): 571-6.
20. Sattar N, Wannamethee G, Sarwar N, Tchernova J, Cherry L, Wallace AM, et al. Adiponectin and coronary heart disease: a prospective study and meta-analysis. Circulation 2006; 114(7): 623-9.
21. Nishizawa H, Shimomura I, Kishida K, Maeda N, Kuriyama H, Nagaretani H, et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 2002; 51(9): 2734-41.
22. Adamczak M, Rzepka E, Chudek J, Wiecek A. Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf) 2005; 62(1): 114-8.
23. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001; 86(5): 1930-5.
24. Ervin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report 2009; (13): 1-7.
25. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006; 189(2): 401-7.
26. Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, et al. Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4). Metabolism 2005; 54(4): 476-81.
27. Kim SM, Cho KH, Park HS. Relationship between plasma adiponectin levels and the metabolic syndrome among Korean people. Endocr J 2006; 53(2): 247-54.
28. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the me- tabolic syndrome. Circ J 2004; 68(11): 975-81.
29. Shojaie M, Sotoodah A, Shafaie G. Is adiponectin associated with acute myocardial infarction in Iranian non obese patients? Lipids Health Dis 2009; 8: 17.
30. Giahi L, Djazayery A, Rahimy A, Rahmany M, Larijani B. Serum level of adiponectin and its association with insu- lin sensitivity in overweight diabetic and non-diabetic Iranian men. Iranian J Publ Health 2008; 37(2): 88-92.
31. Mohebbi H, Moghadasi M, Rahmani-Nia F, Hassan-Nia S, Noroozi H. Association among lifestyle status, plasma adiponectin level and metabolic syndrome in obese middle aged men. Brazilian Journal of Biomotricity 2009; 3(3): 243-52.
32. Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, Heshmat R, Sajadi M, Derakhshan R, et al. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabet Stud 2010; 7(3): 241-6.
33. Hajmohammadi T, Sadeghi M, Dashti M, Hashemi M, Saadatnia M, Soghrati M, et al. Relationship between carotid intima-media thickness with some inflammatory biomarkers, ghrelin and adiponectin in Iranians with and without metabolic syndrome in Isfahan cohort study. ARYA Journal 2010; 6(2): 56-61.
34. International Diabetes Federation Press Conference. The IDF consensus worldwide definition of the metabolic syn- drome [Online] 2005; [cited 2005 Apr 14]. Available from URL: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition. pdf.
35. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15(7): 539-53.
36. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.
37. th ed. Philadelphia: Saunders; 2005. p. 938-52.
38. Wang CH, Wang JH, Lee CJ, Fang TC, Liou HH, Hsu BG. Fasting serum adiponectin level inversely correlates with metabolic syndrome in peritoneal dialysis patients. Blood Purif 2010; 30(1): 1-7.
39. Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulation 2003; 108(13): 1546-51.
40. Reppert A, Steiner BF, Chapman-Novakofski K. Prevalence of metabolic syndrome and associated risk factors in Illinois. Am J Health Promot 2008; 23(2): 130-8.
41. Villegas R, Perry IJ, Creagh D, Hinchion R, O'Halloran D. Prevalence of the metabolic syndrome in middle-aged men and women. Diabetes Care 2003; 26(11): 3198-9.
42. Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, et al. Prevalence of the metabolic syndrome and over- weight among adults in China. Lancet 2005; 365(9468): 1398-405.
43. Li Y, Yang X, Zhai F, Kok FJ, Zhao W, Piao J, et al. Prevalence of the metabolic syndrome in Chinese adolescents. Br J Nutr 2008; 99(3): 565-70.
44. Park HS, Lee SY, Kim SM, Han JH, Kim DJ. Prevalence of the metabolic syndrome among Korean adults accord- ing to the criteria of the International Diabetes Federation. Diabetes Care 2006; 29(4): 933-4.
45. Mirmiran P, Sherafat-Kazemzadeh R, Farahani SJ, Asghari G, Niroomand M, Momenan A, et al. Performance of different definitions of metabolic syndrome for children and adolescents in a 6-year follow-up: Tehran Lipid and Glucose Study (TLGS). Diabetes Res Clin Pract 2010; 89(3): 327-33.
46. Fischer CP, Perstrup LB, Berntsen A, Eskildsen P, Pedersen BK. Elevated plasma interleukin-18 is a marker of insu- lin-resistance in type 2 diabetic and non-diabetic humans. Clin Immunol 2005; 117(2): 152-60.
47. You T, Ryan AS, Nicklas BJ. The metabolic syndrome in obese postmenopausal women: relationship to body com- position, visceral fat, and inflammation. J Clin Endocrinol Metab 2004; 89(11): 5517-22.
48. Salmenniemi U, Ruotsalainen E, Pihlajamaki J, Vauhkonen I, Kainulainen S, Punnonen K, et al. Multiple abnormal- ities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004; 110(25): 3842-8.
49. Wang J, Li H, Franco OH, Yu Z, Liu Y, Lin X. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 2008; 16(1): 172-8.
50. Kumagai S, Kishimoto H, Masatakasuwa, Zou B, Harukasasaki. The leptin to adiponectin ratio is a good biomarker for the prevalence of metabolic syndrome, dependent on visceral fat accumulation and endurance fitness in obese patients with diabetes mellitus. Metab Syndr Relat Disord 2005; 3(2): 85-94.
51. Maynadier M, Basile I, Gary-Bobo M. Adiponectin normalization: a clue to the anti-metabolic syndrome action of rimonabant. Drug Discov Today 2009; 14(3-4): 192-7.
52. Hung J, McQuillan BM, Thompson PL, Beilby JP. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. Int J Obes (Lond) 2008; 32(5): 772-9.
53. Lee S, Bacha F, Gungor N, Arslanian S. Comparison of different definitions of pediatric metabolic syndrome: relation to abdominal adiposity, insulin resistance, adiponectin, and inflammatory biomarkers. J Pediatr 2008; 152(2): 177-84.
54. Tabara Y, Osawa H, Kawamoto R, Tachibana-Iimori R, Yamamoto M, Nakura J, et al. Reduced high-molecular- weight adiponectin and elevated high-sensitivity C-reactive protein are synergistic risk factors for metabolic syn- drome in a large-scale middle-aged to elderly population: the Shimanami Health Promoting Program Study. J Clin Endocrinol Metab 2008; 93(3): 715-22.
55. Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y. Decreased plasma adiponectin concentra- tion in patients with essential hypertension. Am J Hypertens 2003; 16(1): 72-5.
56. Mitsutake R, Miura S, Shiga Y, Uehara Y, Saku K. Association between hypertension and coronary artery disease as assessed by coronary computed tomography. J Clin Hypertens (Greenwich) 2011; 13(3): 198-204.